NSE close · Fri, 25 SeptNifty 5023,140.50▲ 0.34%Nifty Bank55,580.40▲ 0.26%Midcap 10060,906.00▼ 0.14%Smallcap 25018,158.900.02%India VIX12.16▼ 4.18%IT28,160.90▼ 0.17%Auto26,967.90▲ 0.89%Pharma27,003.00▼ 0.10%FMCG45,941.30▲ 0.40%Metal13,087.15▲ 0.35%Realty869.35▲ 0.92%Energy37,440.35▲ 0.21%PSU Bank8,294.50▲ 0.28%Financials25,094.85▲ 0.56%Media1,550.65▼ 0.23%Defence9,401.65▲ 0.43%Durables38,278.60▲ 0.95%Biggest movesTURTLEMINT▼ 20.0%ADSL▲ 20.0%HEROMOTORS▲ 20.0%SHANTIGOLD▲ 14.8%UGARSUGAR▲ 14.8%MAWANASUG▲ 14.5%TGVSL▲ 14.2%UTTAMSUGAR▲ 12.7%

Top stories

Picking up + China · 5 storiesClear filters

Developing 73 Picking up 31 Price moves 1 Following

Busiest tags today

Geopolitics74 Market valuations74 Banks67 Global markets65 Crude oil63 AI58 Nifty and Sensex54 Iran49 Donald Trump36 Gold31 Bond yields30 Stock exchanges25 Trade and tariffs25 China24 Every tag in Market pulse →

Place

China● +10% net tone today

24 stories today · 112 since 24 Sept

Sitharaman said Chinese authorities restrict market access and impose requirements
China asked ByteDance, Alibaba and others to report Nvidia chip purchase plans
China held naval and air exercises near a disputed South China Sea shoal

Often with, this weekUS–China72 Donald Trump38 Xi Jinping37 Trade and tariffs29 AI28

Open tag page →Clear ×

Stories per day

1424 Sept

4825 Sept

2226 Sept

1127 Sept

1728 Sept

Deal▲Picking up

Sun Pharma signs exclusive licensing agreement with LIB Therapeutics Inc.

Sun Pharma secured exclusive rights to commercialize and manufacture Lerodalcibep worldwide, excluding the US and China
The licensing deal gives Sun Pharma a potential global product opportunity outside the US and China

Sun Pharma Pharma and healthcare China2 sources · 27m

●Picking up